Published in PLoS One on January 08, 2013
MicroRNA-21 regulates hTERT via PTEN in hypertrophic scar fibroblasts. PLoS One (2014) 0.89
Crosstalking between androgen and PI3K/AKT signaling pathways in prostate cancer cells. J Biol Chem (2014) 0.87
In vitro and in vivo model systems used in prostate cancer research. J Biol Methods (2015) 0.81
Melittin restores PTEN expression by down-regulating HDAC2 in human hepatocelluar carcinoma HepG2 cells. PLoS One (2014) 0.78
Characterization of Heterogeneous Prostate Tumors in Targeted Pten Knockout Mice. PLoS One (2016) 0.75
Androgen signaling is a confounding factor for β-catenin-mediated prostate tumorigenesis. Oncogene (2015) 0.75
LZTS2 and PTEN collaboratively regulate ß-catenin in prostatic tumorigenesis. PLoS One (2017) 0.75
PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science (1997) 29.34
A global double-fluorescent Cre reporter mouse. Genesis (2007) 17.86
The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem (1998) 17.36
Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature (2005) 15.83
Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet (1997) 15.38
Pten is essential for embryonic development and tumour suppression. Nat Genet (1998) 13.41
New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc Natl Acad Sci U S A (1999) 11.38
Prostate cancer in a transgenic mouse. Proc Natl Acad Sci U S A (1995) 8.16
Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer. Cancer Cell (2003) 8.11
Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems. Proc Natl Acad Sci U S A (1999) 7.88
Reciprocal feedback regulation of PI3K and androgen receptor signaling in PTEN-deficient prostate cancer. Cancer Cell (2011) 7.32
The lipid phosphatase activity of PTEN is critical for its tumor supressor function. Proc Natl Acad Sci U S A (1998) 6.98
High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice. Curr Biol (1998) 6.38
Molecular genetics of prostate cancer. Genes Dev (2000) 5.18
Frequent inactivation of PTEN/MMAC1 in primary prostate cancer. Cancer Res (1997) 4.73
Generation of a prostate epithelial cell-specific Cre transgenic mouse model for tissue-specific gene ablation. Mech Dev (2001) 4.47
Cell autonomous role of PTEN in regulating castration-resistant prostate cancer growth. Cancer Cell (2011) 4.43
Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues. Cancer Res (1998) 4.33
Loss of PTEN expression in paraffin-embedded primary prostate cancer correlates with high Gleason score and advanced stage. Cancer Res (1999) 3.29
High incidence of breast and endometrial neoplasia resembling human Cowden syndrome in pten+/- mice. Cancer Res (2000) 3.24
PTENless means more. Dev Biol (2004) 2.31
Targeted biallelic inactivation of Pten in the mouse prostate leads to prostate cancer accompanied by increased epithelial cell proliferation but not by reduced apoptosis. Cancer Res (2005) 2.19
Mutations of the human PTEN gene. Hum Mutat (2000) 2.11
Phosphatidylinositol 3-kinase/Akt stimulates androgen pathway through GSK3beta inhibition and nuclear beta-catenin accumulation. J Biol Chem (2002) 2.08
Homozygous deletion of the PTEN tumor suppressor gene in a subset of prostate adenocarcinomas. Clin Cancer Res (1998) 1.83
Combinatorial activities of Akt and B-Raf/Erk signaling in a mouse model of androgen-independent prostate cancer. Proc Natl Acad Sci U S A (2006) 1.78
Early onset of neoplasia in the prostate and skin of mice with tissue-specific deletion of Pten. Proc Natl Acad Sci U S A (2004) 1.67
Pten inactivation and the emergence of androgen-independent prostate cancer. Cancer Res (2007) 1.59
Physiological functions of Pten in mouse tissues. Cell Struct Funct (2003) 1.36
Exploring the origins of the normal prostate and prostate cancer stem cell. Stem Cell Rev (2008) 1.32
Prostate epithelial cell fate. Differentiation (2008) 1.13
Antagonism between PTEN/MMAC1/TEP-1 and androgen receptor in growth and apoptosis of prostatic cancer cells. J Biol Chem (2001) 1.13
Faithfull modeling of PTEN loss driven diseases in the mouse. Curr Top Microbiol Immunol (2010) 1.11
A Cre transgene active in developing endodermal organs, heart, limb, and extra-ocular muscle. Genesis (2008) 0.93
Depleting tumor-specific Tregs at a single site eradicates disseminated tumors. J Clin Invest (2013) 2.77
Linking beta-catenin to androgen-signaling pathway. J Biol Chem (2002) 2.27
Phosphatidylinositol 3-kinase/Akt stimulates androgen pathway through GSK3beta inhibition and nuclear beta-catenin accumulation. J Biol Chem (2002) 2.08
The androgen receptor negatively regulates the expression of c-Met: implications for a novel mechanism of prostate cancer progression. Cancer Res (2007) 1.99
Roles and regulation of Wnt signaling and beta-catenin in prostate cancer. Cancer Lett (2005) 1.90
Serum miRNA-21: elevated levels in patients with metastatic hormone-refractory prostate cancer and potential predictive factor for the efficacy of docetaxel-based chemotherapy. Prostate (2010) 1.81
External validation of a nomogram using RENAL nephrometry score to predict high grade renal cell carcinoma. J Urol (2012) 1.58
Wnt3a growth factor induces androgen receptor-mediated transcription and enhances cell growth in human prostate cancer cells. Cancer Res (2004) 1.53
High Performance In Vivo Near-IR (>1 μm) Imaging and Photothermal Cancer Therapy with Carbon Nanotubes. Nano Res (2010) 1.51
The fate and toxicity of Raman-active silica-gold nanoparticles in mice. Sci Transl Med (2011) 1.50
Development and evaluation of a nomogram to predict inguinal lymph node metastasis in patients with penile cancer and clinically negative lymph nodes. J Urol (2010) 1.49
Comparison of the acute inflammatory response of two commercial platelet-rich plasma systems in healthy rabbit tendons. Am J Sports Med (2012) 1.45
Defining good candidates for extraperitoneal cystectomy: results from random peritoneum biopsies of 136 cases. Urology (2013) 1.45
Erythrocyte sedimentation rate kinetics as a marker of treatment response and predictor of prognosis in Chinese metastatic renal cell carcinoma patients treated with sorafenib. Int J Urol (2011) 1.44
hZimp10 is an androgen receptor co-activator and forms a complex with SUMO-1 at replication foci. EMBO J (2003) 1.28
Mechanism of p21-activated kinase 6-mediated inhibition of androgen receptor signaling. J Biol Chem (2003) 1.24
A promoting role of androgen receptor in androgen-sensitive and -insensitive prostate cancer cells. Nucleic Acids Res (2007) 1.22
The novel PIAS-like protein hZimp10 enhances Smad transcriptional activity. J Biol Chem (2006) 1.22
Modulating the strength and threshold of NOTCH oncogenic signals by mir-181a-1/b-1. PLoS Genet (2012) 1.15
Human microRNA-27a* targets Prf1 and GzmB expression to regulate NK-cell cytotoxicity. Blood (2011) 1.15
Twist1 suppresses senescence programs and thereby accelerates and maintains mutant Kras-induced lung tumorigenesis. PLoS Genet (2012) 1.15
A multiplex model of combining gene-based, protein-based, and metabolite-based with positive and negative markers in urine for the early diagnosis of prostate cancer. Prostate (2010) 1.11
hZimp7, a novel PIAS-like protein, enhances androgen receptor-mediated transcription and interacts with SWI/SNF-like BAF complexes. Mol Endocrinol (2005) 1.11
LZTS2 is a novel beta-catenin-interacting protein and regulates the nuclear export of beta-catenin. Mol Cell Biol (2006) 1.07
External validation of the Prostate Cancer Prevention Trial and the European Randomized Study of Screening for Prostate Cancer risk calculators in a Chinese cohort. Asian J Androl (2012) 1.05
Identification of tyrosine kinases overexpressed in head and neck cancer. Arch Otolaryngol Head Neck Surg (2004) 1.04
In vivo evidence for alcohol-induced neurochemical changes in rat brain without protracted withdrawal, pronounced thiamine deficiency, or severe liver damage. Neuropsychopharmacology (2008) 1.03
Efficacy of c-Met inhibitor for advanced prostate cancer. BMC Cancer (2010) 1.03
Brain injury and recovery following binge ethanol: evidence from in vivo magnetic resonance spectroscopy. Biol Psychiatry (2009) 1.02
Human regulatory factor X 4 (RFX4) is a testis-specific dimeric DNA-binding protein that cooperates with other human RFX members. J Biol Chem (2001) 1.00
New N staging system of penile cancer provides a better reflection of prognosis. J Urol (2011) 0.99
A novel clinically translatable fluorescent nanoparticle for targeted molecular imaging of tumors in living subjects. Nano Lett (2011) 0.99
Ultra-low doses of chirality sorted (6,5) carbon nanotubes for simultaneous tumor imaging and photothermal therapy. ACS Nano (2013) 0.98
Visceral obesity and risk of high grade disease in clinical t1a renal cell carcinoma. J Urol (2012) 0.97
Heme oxygenase-1 deletion affects stress erythropoiesis. PLoS One (2011) 0.97
Beta-catenin is involved in insulin-like growth factor 1-mediated transactivation of the androgen receptor. Mol Endocrinol (2004) 0.97
Thioredoxin-interacting protein regulates hematopoietic stem cell quiescence and mobilization under stress conditions. J Immunol (2009) 0.96
Individualized prostate biopsy strategy for Chinese patients with different prostate-specific antigen levels. Asian J Androl (2007) 0.96
Prostate-specific antigen half-life: a new predictor of progression-free survival and overall survival in Chinese prostate cancer patients. Asian J Androl (2009) 0.96
Downregulation of DAB2IP results in cell proliferation and invasion and contributes to unfavorable outcomes in bladder cancer. Cancer Sci (2014) 0.95
TOX regulates the differentiation of human natural killer cells from hematopoietic stem cells in vitro. Immunol Lett (2010) 0.95
Molecular imaging of inflammation in inflammatory bowel disease with a clinically translatable dual-selectin-targeted US contrast agent: comparison with FDG PET/CT in a mouse model. Radiology (2013) 0.94
The novel PIAS-like protein hZimp10 is a transcriptional co-activator of the p53 tumor suppressor. Nucleic Acids Res (2007) 0.94
The PIAS-like protein Zimp10 is essential for embryonic viability and proper vascular development. Mol Cell Biol (2007) 0.93
Tumor cytoreduction results in better response to androgen ablation--a preliminary report of palliative transurethral resection of the prostate in metastatic hormone sensitive prostate cancer. Urol Oncol (2010) 0.92
An elevated serum miR-141 level in patients with bone-metastatic prostate cancer is correlated with more bone lesions. Asian J Androl (2013) 0.92
c-KIT: potential predictive factor for the efficacy of sorafenib in metastatic renal cell carcinoma with sarcomatoid feature. Clin Genitourin Cancer (2012) 0.92
High-contrast in vivo visualization of microvessels using novel FeCo/GC magnetic nanocrystals. Magn Reson Med (2009) 0.90
Down-regulation of Dicer and Ago2 is associated with cell proliferation and apoptosis in prostate cancer. Tumour Biol (2014) 0.90
Measurement of serum, liver, and brain cytokine induction, thiamine levels, and hepatopathology in rats exposed to a 4-day alcohol binge protocol. Alcohol Clin Exp Res (2010) 0.89
Primary yolk sac tumor of seminal vesicle: a case report and literature review. World J Surg Oncol (2012) 0.89
Prognostic factors in Chinese patients with metastatic castration-resistant prostate cancer treated with docetaxel-based chemotherapy. Asian J Androl (2012) 0.89
Prospectively packaged ilioinguinal lymphadenectomy for penile cancer: the disseminative pattern of lymph node metastasis. J Urol (2009) 0.89
Zimp7 and Zimp10, two novel PIAS-like proteins, function as androgen receptor coregulators. Nucl Recept Signal (2006) 0.87
Prevalence of incidental prostate cancer in patients undergoing radical cystoprostatectomy: data from China and other Asian countries. Asian J Androl (2008) 0.86
Deletion of leucine zipper tumor suppressor 2 (Lzts2) increases susceptibility to tumor development. J Biol Chem (2012) 0.86
A novel role for protein inhibitor of activated STAT (PIAS) proteins in modulating the activity of Zimp7, a novel PIAS-like protein, in androgen receptor-mediated transcription. J Biol Chem (2010) 0.86
Contrast-enhanced C-arm CT evaluation of radiofrequency ablation lesions in the left ventricle. JACC Cardiovasc Imaging (2011) 0.86
Conditional expression of the androgen receptor induces oncogenic transformation of the mouse prostate. J Biol Chem (2011) 0.86
Validation of the prognostic value of lymph node ratio in patients with penile squamous cell carcinoma: a population-based study. Int Urol Nephrol (2013) 0.86
Narrow-band imaging flexible cystoscopy in the detection of primary non-muscle invasive bladder cancer: a "second look" matters? Int Urol Nephrol (2011) 0.85
Feasibility and activity of sorafenib and sunitinib in advanced penile cancer: a preliminary report. Urol Int (2010) 0.85
Lymph node metastases and prognosis in penile cancer. Chin J Cancer Res (2012) 0.85
A mechanism of rapidly reversible cerebral ventricular enlargement independent of tissue atrophy. Neuropsychopharmacology (2013) 0.84
Infection of pregnant mice with Listeria monocytogenes induces fetal bradycardia. Pediatr Res (2012) 0.83
Penile metastasis from primary bladder cancer: a study of 8 cases and review of the literature. Onkologie (2012) 0.83
Pretreatment Neutrophil-to-Lymphocyte Ratio: A Predictor of Advanced Prostate Cancer and Biochemical Recurrence in Patients Receiving Radical Prostatectomy. Medicine (Baltimore) (2015) 0.83
Influence of obesity on localized prostate cancer patients treated with radical prostatectomy. Asian J Androl (2013) 0.83
A nomogram to predict Gleason sum upgrading of clinically diagnosed localized prostate cancer among Chinese patients. Chin J Cancer (2014) 0.83
Rat strain differences in brain structure and neurochemistry in response to binge alcohol. Psychopharmacology (Berl) (2013) 0.82
Ineffective vaccination against solid tumors can be enhanced by hematopoietic cell transplantation. J Immunol (2009) 0.82
The value of squamous cell carcinoma antigen in the prognostic evaluation, treatment monitoring and followup of patients with penile cancer. J Urol (2008) 0.82
Association between plasma hepatocyte growth factor and gefitinib resistance in patients with advanced non-small cell lung cancer. Lung Cancer (2011) 0.82
The leucine zipper putative tumor suppressor 2 protein LZTS2 regulates kidney development. J Biol Chem (2011) 0.81
Prevalence of dyslipidaemia in patients with renal cell carcinoma: a case-control study in China. BJU Int (2014) 0.81
Organ-sparing surgery for penile cancer: complications and outcomes. Urology (2011) 0.81
Primary invasive carcinoma associated with penoscrotal extramammary Paget's disease: a clinicopathological analysis of 56 cases. BJU Int (2014) 0.81
The beta-catenin binding protein ICAT modulates androgen receptor activity. Mol Endocrinol (2011) 0.81
VDUP1 exacerbates bacteremic shock in mice infected with Pseudomonas aeruginosa. Cell Immunol (2012) 0.81
Pseudomonas aeruginosa eliminates natural killer cells via phagocytosis-induced apoptosis. PLoS Pathog (2009) 0.81
Development of a nomogram to predict non-organ-confined bladder urothelial cancer before radical cystectomy. Int Urol Nephrol (2012) 0.80
Population-based assessment of the number of lymph nodes removed in the treatment of penile squamous cell carcinoma. Urol Int (2013) 0.80
ZMIZ1 preferably enhances the transcriptional activity of androgen receptor with short polyglutamine tract. PLoS One (2011) 0.80
Identification and characterization of an epididymis-specific gene, Ces7. Acta Biochim Biophys Sin (Shanghai) (2009) 0.80
A nomogram to predict the duration of drainage in patients with penile cancer treated with inguinal lymph node dissection. J Urol (2011) 0.80
Cyclin D1 and p16 expression in recurrent nasopharyngeal carcinoma. World J Surg Oncol (2006) 0.80
Narrow-band imaging flexible cystoscopy in the detection of clinically unconfirmed positive urine cytology. Urol Int (2011) 0.80
A novel zinc finger transcription factor with two isoforms that are differentially repressed by estrogen receptor-alpha. J Biol Chem (2002) 0.79
External validation of nomograms for predicting cancer-specific mortality in penile cancer patients treated with definitive surgery. Chin J Cancer (2014) 0.79
Autophagy downregulates thrombin-induced VSMCs proliferation through lysosomal pathway. Int J Cardiol (2012) 0.79